These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 60596)

  • 1. Letter: Induction of hepatic cortisol-6-hydroxylase by rifampicin.
    Yamada S; Iwai K
    Lancet; 1976 Aug; 2(7981):366-7. PubMed ID: 60596
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in cortisol metabolism following rifampicin therapy.
    Edwards OM; Courtenay-Evans RJ; Galley JM; Hunter J; Tait AD
    Lancet; 1974 Sep; 2(7880):548-51. PubMed ID: 4140269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic mixed function oxidase induction during rifampicin/isoniazid therapy in Indian vegetarians.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):344-8. PubMed ID: 3733284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R; Arioli V; Furesz S; Bolzoni G
    Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
    Tousek J; Votruba R
    Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isoniazid and rifampicin in the rabbit. Effect on hepatic microsomal enzyme activity].
    Kergueris MF; Larousse C; Le Normand Y; Guillerme G; Bourin M
    J Pharmacol; 1982; 13(4):525-34. PubMed ID: 7154665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 8. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1970 Sep; 102(3):347-55. PubMed ID: 4989604
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].
    Engbaek HC; Larsen SO; Rasmussen KN; Vergmann B
    Ugeskr Laeger; 1973 Aug; 135(34):1795-9. PubMed ID: 4592618
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rifampicin in the treatment of lung and kidney tuberculosis].
    Kraan JK; Mulder RJ; Mulder-De Jong MT; van Dijk B
    Ned Tijdschr Geneeskd; 1972 Jan; 116(1):9-15. PubMed ID: 4555064
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 14. [Five year follow-up study on the short-course chemotherapy for pulmonary tuberculosis in Niigata Prefecture].
    Hashimoto T; Shimao T; Aoki M; Misawa H; Takasawa N; Shiozawa S
    Kekkaku; 1984 Jun; 59(6):369-76. PubMed ID: 6492547
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rifamicin in the studies of the Scuola Tisiologica in Naples].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):271-92. PubMed ID: 4981409
    [No Abstract]   [Full Text] [Related]  

  • 16. Initial treatment of tuberculosis with streptomycin and isoniazid combined with either aminosalyl or rifampicin.
    Engbaek HC; Larsen SO; Rasmussen KN; Vergmann B
    Scand J Respir Dis; 1973; 54(2):83-91. PubMed ID: 4122479
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperlipidaemia as a complication of rifampicin treatment.
    Khogali AM; Chazan BI; Metcalf VJ; Ramsay JH
    Tubercle; 1974 Sep; 55(3):231-3. PubMed ID: 4470842
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugs.
    Eidus L; Jessamine AG; Helbaque DM; Narasimhan V
    Int J Clin Pharmacol; 1974 Jan; 9(1):81-6. PubMed ID: 4593132
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity.
    Brodie MJ; Boobis AR; Hillyard CJ; Abeyasekera G; MacIntyre I; Park BK
    Clin Pharmacol Ther; 1981 Sep; 30(3):363-7. PubMed ID: 7273600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proceedings: Rifampicin adverse effects in intermittent therapy].
    Herrmann H; Eule H; Lau W; Kuhnert R; Fanter D; Kahlau U; Schönert E; Werner E
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):146-58. PubMed ID: 4491712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.